Three-dimensional visualization and quantification for the growth and invasion of oral squamous cell carcinoma

Japanese Dental Science Review

Volumn 46, Issue 1, 2010, Pages 17-25

  Shimazu, Yoshihito ^a   Kudo, Tomoo ^a   Yagishita, Hisao ^a   Aoba, Takaaki ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

3D reconstruction; Histopathology; Immunohistochemistry; Invasion front; Oral squamous cell carcinoma

Indexed keywords

EID: 74449090933     PISSN: 18827616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdsr.2009.09.002     Document Type: Review

References (52)

1. Ziober B.L., Silverman S.S., and Kramer R.H. Adhesive mechanisms regulating invasion and metastasis in oral cancer. Crit Rev Oral Biol Med 12 (2001) 499-510
2. Pentenero M., Gandolfo S., and Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 27 (2005) 1080-1091
3. Kademani D. Oral cancer. Mayo Clin Proc 82 (2007) 878-887
4. Christofori G. New signals from the invasive front. Nature 441 (2006) 444-450
5. Joyce J.A., and Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 9 (2009) 239-252
6. Polyak K., and Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9 (2009) 2652-3273
7. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 (1996) 2488-2492
8. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., and Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 170 (2007) 1807-1816
9. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337
10. Jain R.K. Molecular regulation of vessel maturation. Nat Med 9 (2003) 685-693
11. Luo J., Solimini N.L., and Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136 (2009) 823-837
12. Braumann U.D., Kuska J.P., Einenkel J., Horn L.C., Loffler M., and Hockel M. Three-dimensional reconstruction and quantification of cervical carcinoma invasion fronts from histological serial sections. IEEE Trans Med Imaging 24 (2005) 1286-1307
13. Gijtenbeek J.M.M., Wesseling P., Maass C., Burgers L., and van der Laak J.A.W.M. Three-dimensional reconstruction of tumor microvasculature: simultaneous visualization of multiple components in paraffin-embedded tissue. Angiogenesis 8 (2005) 297-305
14. Wentzensen N., Braumann U.D., Einenkel J., Horn L.C., Doeberitz M.K., Loffler M., et al. Combined serial section-based 3D reconstruction of cervical carcinoma invasion using H&E/p16INK4a/CD3 alternate staining. Cytometry A 71A (2007) 327-333
15. Fukumura D., and Jain R.K. Imaging angiogenesis and the microenvironment. APMIS 116 (2008) 695-715
16. In: Shimazu Y., and Aoba T. (Eds). Three-dimensional motion view of tissue architectures and lesions (2009), Ishiyaku Pub., Tokyo [in Japanese]
17. Kay P.A., Robb R.A., and Bostwick D.G. Prostate cancer microvessels: a novel method for three-dimensional reconstruction and analysis. Prostate 37 (1998) 270-277
18. Einenkel J., Kuska J.P., Horn L.C., Wentzensen N., Hockel M., and Braumann U.D. Combined three-dimensional microscopic visualisation of tumour-invasion front of cervical carcinoma. Lancet Oncol 7 (2006) 698
19. Lin A., Ai Z., Lee S.C., Bajcsy P., Péer J., Leach L., et al. Comparing vasculogenic mimicry with endothelial cell lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks. Appl Immunohistochem Mol Morphol 15 (2007) 113-119
20. Dickie R., Bachoo R.M., Rupnick M.A., Dallabrida S.M., DeLoid G.M., Lai J., et al. Three-dimensional visualization of microvessel architecture of whole-mount tissue by confocal microscopy. Microvasc Res 72 (2006) 20-26
21. Hossler F.E., and Douglas J.E. Vascular corrosion casting: review of advantages and limitations in the application of some simple quantitative methods. Microsc Microanal 7 (2001) 253-264
22. Weninger W.J., and Mohun T. Phenotyping transgenic embryos: a rapid 3-D screening method based on episcopic fluorescence image capturing. Nat Genetics 30 (2002) 59-65
23. Yamamoto E., Kohama G., and Sunagawa H. Mode of invasion: bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 51 (1983) 2175-2180
24. Crissman J.D., Liu W.Y., Gluckman J.L., and Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 54 (1984) 2995-3001
25. Asakage T., Yokose T., Mukai K., Tsugane S., Tsubono Y., Asai M., et al. Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer 82 (1998) 1443-1448
26. Sheahan P., O'Keane C., Sheahan J.N., and O'Dwyer T.P. Predictors of survival in early oral cancer. Otolaryngol Head Neck Surg 129 (2003) 571-576
27. Keski-Säntti H., Atula T., Törnwall J., Koivunen P., and Mäkitie A. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 42 (2006) 96-101
28. Bryne M., Koppang H.S., Lilleng R., and Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166 (1992) 375-381
29. Woolgar J.A. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 42 (2006) 229-239
30. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication?. Oral Dis 4 (1998) 70-77
31. Sawair F.A., Irwin C.R., Gordon D.J., Leonard A.G., Stephenson M., and Napier S.S. Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med 32 (2003) 1-9
32. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 (1995) 27-31
33. Jubb A.M., Oates A.J., Holden S., and Koeppen H. Predicting benefit from anti-angiogenic agents in malignancy. Nat Rev Cancer (2007) S5-S14
34. Eberhard A., Kahlert S., Goede V., Hemmerlein B., Plate K.H., and Augustin H.G. Heterogeneity of angiogenesis and blood vessel maturation in human tumours: implications for antiangiogenic tumour therapies. Cancer Res 60 (2000) 1388-1393
35. Tozer G.M., Kanthou C., and Baguley B.C. Disrupting tumour blood vessels. Nat Rev Cancer 5 (2005) 423-435
36. Ribatti D., Nico B., Crivellato E., and Vacca A. The structure of the vascular network of tumors. Cancer Lett 248 (2007) 18-23
37. Adams R.H., and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8 (2007) 464-478
38. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
39. Mazzone M., Dettori D., Leite de Oliveira R., Loges S., Schmidt T., Jonckx B., et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136 (2009) 839-851
40. Bautch V.L. Endothelial cells form a phalanx to block tumor metastasis. Cell 136 (2009) 810-812
41. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147 (1995) 9-19
42. Kahn H.J., Bailey D., and Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 15 (2002) 434-440
43. Evangelou E., Kyzas P.A., and Trikalinos T.A. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol 18 (2005) 1490-1497
44. Baluk P., and McDonald D.M. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann NY Acad Sci 1131 (2008) 1-12
45. Beasley N.J.P., Prevo R., Banerji S., Leek R.D., Moore J., van Trappen P., et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62 (2002) 1315-1320
46. Franchi A., Gallo O., Massi D., Baroni G., and Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 101 (2004) 973-978
47. Maula S.-M., Luukkaa M., Grénman R., Jackson D., Jalkanen S., and Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63 (2003) 1920-1926
48. Sedivy R., Beck-Mannagetta J., Haverkampf C., Battistutti W., and Honigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 32 (2003) 455-460
49. Ohno F., Nakanishi H., Abe A., Seki Y., Kinoshita A., Hasegawa Y., et al. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis. J Oral Pathol Med 36 (2007) 281-289
50. Van der Auwera I., Cao Y., Tille J.C., Pepper M.S., Jackson D.G., Fox S.B., et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 95 (2006) 1611-1625
51. Padera T.P., Kadambi A., di Tomaso E., Carreira C.M., Brown E.B., Boucher Y., et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296 (2002) 1883-1886
52. Cairns R.A., Khokha R., and Hill R.P. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 3 (2003) 659-671